Zhonglin Zhang
No. 169 Donghu Road
Wuhan, 430071, China
Wuhan, 430071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Rictor mediates p53 deactivation to facilitate the malignant transformation of hepatocytes and promote hepatocarcinogenesis.
Journal: Journal of translational medicine
Published: October 16, 2023
RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4.
Journal: Oncogene
Published: June 19, 2023
Cullin-associated and neddylation-dissociated 1 regulate reprogramming of lipid metabolism through SKP1-Cullin-1-F-boxFBXO11 -mediated heterogeneous nuclear ribonucleoprotein A2/B1 ubiquitination and promote hepatocellular carcinoma.
Journal: Clinical and translational medicine
Published: June 12, 2023
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
Journal: Journal of hepatology
Published: August 21, 2022
DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: August 17, 2022
METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.
Journal: Cancer communications (London, England)
Published: June 16, 2022
A patient with glycogen storage disease type IA combined with hepatic adenoma: A case report.
Journal: Genes & diseases
Published: January 10, 2022
Last Updated: 09/26/2026